Cerebral perfusion and cognitive impairment in patients with vascular dementia


In the article results of the own investigation of cerebral perfusion in patients with different forms of vascular dementia are quoted. The investigation embraces the patients with different variants of clinical course of vascular dementia, including it's mixed (vascular-neurodegenerative) forms. Perfusion evaluation has performed by single-photon emission tomography (SPECT) with contrast strengthening. All patients were evaluated by complex neuropsychological scales. Basing on comparison of Cnnical data, neuropsychological measures and cerebral perfusion, the patterns of cognitive disorders in the case of different hypoperfusion zones were marked. The significance of inadequate blood supply even without structural changes in the manifestation of cognitive decline was demonstrated. Single-photon emission computer tomography allows to prognose the cognitive impairment progression in the dynamic evaluation.

M M Odinak

S. M. Kirov Military Medical Academy

A Yu Emelin

S. M. Kirov Military Medical Academy

V Yu Lobzin

S. M. Kirov Military Medical Academy

Email: vladimirlobzin@mail.ru

V S Dekan

S. M. Kirov Military Medical Academy

V V Dremov

S. M. Kirov Military Medical Academy

A V Kashin

S. M. Kirov Military Medical Academy

M V Rezvantsev

S. M. Kirov Military Medical Academy

  1. Божко О.В. Магнитно-резонансная томография подкоркового поражения головного мозга при болезни Альцгеймера // 2007. № 7. 0420700015/0003.
  2. Гаврилова С.И. Фармакотерапия болезни Альцгеймера. М.: Пульс, 2003. 337 с.
  3. Дамулин И.В., Левин О.С., Яхно Н.Н. Болезнь Альцгеймера: клинико-МРТ-исследование // Неврол. журн. 1999. № 2. С. 34-38.
  4. Левин О.С., Дамулин И.В. Диффузные изменения белого вещества [лейкоареоз] и проблема сосудистой деменции // Достижения в нейрогериатрии / Под ред. Н.Н. Яхно, И.В. Дамулина. М.: ММА, 1995. С. 189-231.
  5. Левин О.С., Усольцева Н.И., Юнищенко Н.А. Постинсультные когнитивные нарушения: механизмы развития и подходы к лечению // Трудный пациент. 2007. Т. 5. № 8. С. 29-36.
  6. Одинак М.М., Емелин А.Ю., Лобзин В.Ю. Нарушение когнитивных функций при цереброваскулярной патологии. СПб.: ВМедА, 2006. 158 с.
  7. Одинак М.М., Емелин А.Ю., Лобзин В.Ю., Кол- чева Ю.А. Терапия сосудистых когнитивных расстройств // Рус. мед. журн. 2009. Т. 17. № 20 (359). С. 1295-1297.
  8. Burton E.J., Kenny R.A., O’Brien J. et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients // Stroke. 2004. ѴЫ. 6. № 35. P. 1270-1275.
  9. Camargo E.E. Brain SPECT in Neurology and Psychiatry // J. of Nucl. Med. 2001. Vol. 42. № 4. P. 611- 623.
  10. Capizzano A.A., Acion L., Bekinschtein T. et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer’s disease II J. Neurol. Neurosurg. Psychiatry. 2004. ѴЫ. 75. P. 822-827.
  11. Cummings J.L., Benson D.F. Dementia: A clinical approach. 2-nd ed. Boston: Butterworths-Heinemann, 1992. 165 p.
  12. de Groot J.C., de Leeuw F.E., Oudkerk M. et al. Cerebral white matter lesions and subjective cognitive disfunction: the Rotterdam scan study // Neurology. 2001. Vol. 56. P. 1539-1545.
  13. DeCarly C. Vascular factors in dementia: an overview // J. Neurol. Sci. 2004. Vol. 226. P. 19-23.
  14. Di Carlo A., Baldereschi M., Amaducci L. et al. Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy: the ILSA Study // J. Am. Geriatr. Soc. 2002. Vol. 50. P.41-48.
  15. Dubois B., Slachevsky A., Litvan I. et al. The FAB A frontal assessment battery at bedside // Neurology. 2000. Vol. 55. P. 1621-1626.
  16. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia // J. Neural. Transm. 2002. Vol. 63 (Suppl.). P. 91-109.
  17. Esiri M.M. Which vascular lesions are of importance in vascular dementia? // Ann. of the N. Y. Acad. Sci. 2000. Vol. 903. P. 239-243.
  18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician // J. of Psychiatric Res. 1975. Vol. 12. P. 189-198.
  19. Geldmacher D.S. Treatment guidelines for alzheimer’s disease: Redefining perceptions in primary care // J. Clin. Psychiatry. 2007. Vol. 9. № 2. P. 114-121.
  20. Gunning-Dixon F.M., Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review//Neuropsychology. 2000. Vol. 2. № 14. P. 224-232.
  21. Hanyu H., Shimizu S., Tanaka Y. Differences in regional cerebral blood flow patterns in male versus female patients with Alzheimer disease //Am. J. Neuroradiol. 2004. Vol. 25. P. 1199-1204.
  22. Hebert R., Lindsay J., Verreault R. et al. Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging // Stroke. 2000. Vol. 31. P. 1487-1493.
  23. Hirono N., Kitagaki H., Kazui H. et al. Impact of white matter changes on clinical manifestation of Alzheimer’s disease // Stroke. 2000. ѴЫ. 31. P. 21-82.
  24. Jellinger K.A. The enigma of vascular cognitive disorder and vascular dementia // Acta Neuropatologica. 2007. Vol. 113. № 4. P. 349-388.
  25. Kenneth M.L., Foster N.L., Larson E.B. et al. Mixed dementia emerging concepts and therapeutic implications // JAMA. 2004. Vol. 292. P. 2901-2908.
  26. Kovari E., Gold G., Herrmann F.R. et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging // Stroke. 2004. Vol. 35. P. 410- 414.
  27. Kramer J.H., Nelson A., Johnson J.K. et al. Multiple cognitive deficits in amnestic mild cognitive impairment // Dement. Geriatr. Cogn. Dis. 2006. Vol. 22. №4. P. 306-311.
  28. Kramer J.H., Reed B.R., Mungas D. et al. Executive dysfunction in subcortical ischaemic vascular disease // J. Neurol. Neurosurg. Psychiatry. 2002. Vol. 72. P. 217- 220.
  29. Krishnan K.R.R., Boyko O.B., Figiel G.S. Imaging in psychiatric disorders // Neuroimaging: A Companion to Adams and Victor’s Principles of Neurology / Ed. J.O. Greenberg. New York, 1995. P. 227-250.
  30. Lobotesis K., Fenwick J.D., Phipps A. Occipital hypoperfusion on БРЕСТ in dementia with Lewy bodies but not AD // Neurology. 2001. Vol. 56. P. 643-649.
  31. Looi J.C.L., Sachdev P.S. Vascular dementia as a frontal subcortical system dysfunction // Psychol. Med. 2000. Vol. 30. № 5. P 997-1003.
  32. Malakouti K., Gaviria M. How could neuroimaging be helpful in the assessment of dementia in a clinical setting? // Acta Medica Iranica. 2002. Vol. 40. № 3. P. 159-164.
  33. Mattis S. Mental status examination for organic mental syndrome in the elderly patient / in Geriatric Psychiatry // Ed. R. Bellack, B. Karasu. New York: Grune & Stratton, 1976. P. 77-121.
  34. Nagata K., Maruya H., Yuya H. et al. Can PET data differentiate Alzheimer’: disease from vascular dementia? //Ann. of the New York Acad. Sci. 2000. Vol. 903. P. 252-261.
  35. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis // Stroke. 1997. Vol. 28. P. 652-659.
  36. Petrella J.R.P., Coleman R.E., Doralswamy P.M. Neuroimaging and early diagnosis of Alzheimer disease: a look to the future // Radiology. 2003. Vol. 226. № 2. P. 315-336.
  37. Piguet O., Ridley L., Grayson D.A. et al. Are MR1 white matter lesions clinically significant in the ‘old- old’? Evidence from the Sydney Older Persons Study // Dement. Geriatr. Cogn. Dis. 2003. Vol. 15. № 3. P. 143-150.
  38. Quarantelli M., Pappata S., Varrone A. Regional CBF in Alzheimer’s disease versus mild cognitive impairment: a SPECT study with partial volume effect // J. Nucl. Med. 2004. Vol. 45. P. 192-201.
  39. Roman G.C., Erkinjuntti T, Wallin A. et al. Subcortical ischaemic vascular dementia // Lancet Neurol. 2002. № 1. P. 426-436.
  40. Ruitenberg A., Ott A., van Swieten J.C. et al. Incidence of dementia: does gender make a difference? // Neuro- biol. Aging. 2001. Vol. 22. P. 575-578.
  41. Scheltens P, Kitter B. Preliminary results from a MR1 / CT-based data base for vascular dementia and Alzheimer’s disease //Ann. NY Acad. Sci. 2000. Vol. 903. P. 542-546.
  42. Soderlund H., Nyberg L., Adolfsson R. et al. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition // Cortex. 2003. Vol. 39. № 4/5. P. 1093-1105.
  43. Strub R.L. Vascular dementia // The Ochsner J. 2003. Vol. 5. P. 40-A3.
  44. Talbot PR., Lloyd J.J., Snowden J.S. et al. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? // J. Neurol. Neurosurg. Psychiatry. 1998. № 64. P 306-313.
  45. van Swieten J.C., Staal S., Kappelle L.J. et al. Are white matter lesions directly associated with cognitive impainnent in patients with lacunar infarcts? // Neurol. J. 1996. Vol. 243. P. 196-200.
  46. Vermeer S.E., Hollander M., van Dijk E.J. et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study // Stroke. 2003. Vol. 34. P. 1126-1129.
  47. Wahlund L.O., Almkvist O., Basun H. et al. MR1 in successful aging, a 5-year follow-up study from the eighth to ninth decade of life // Magn. Reson. Imaging. 1996. Vol. 14. P 601-608.
  48. Wen H., Мок V, Fan Y. et al. Effect of white matter changes on cognitive impairment in patients with lacunar infarcts // Stroke. 2004. Vol. 35. P. 1826- 1836.


Abstract - 39



  • There are currently no refbacks.

Copyright (c) 2011 Odinak M.M., Emelin A.Y., Lobzin V.Y., Dekan V.S., Dremov V.V., Kashin A.V., Rezvantsev M.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.